Second Sight Announces First Age-Related Macular Degeneration Patient Receives Argus II Retinal Prosthesis System

Second Sight Medical Products, Inc. EYES ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that restore some useful vision to blind patients, today announced the first implant and successful activation of the Argus® II Retinal Prosthesis System (Argus II) in a dry age-related macular degeneration (AMD) patient. The implant is part of a feasibility study which aims to evaluate the safety and utility of the Argus II System in individuals with late-stage Dry AMD, a condition that severely affects their central vision. The implant was performed at the Manchester Royal Eye Hospital in the United Kingdom by Dr. Paulo Stanga MD, Consultant Ophthalmologist & Vitreoretinal Surgeon at the Manchester Royal See full press release